Phase II trial of concurrent Nivolumab and radiation therapy in chemotherapy ineligible muscle invasive bladder cancer [NUTRA trial NCT03421652]

被引：0
|
作者：
George, Saby [2 ]
Heilbrun, Lance [1 ]
Maier, Jordan [3 ]
Dickow, Brenda [3 ]
Kuettel, Michael [2 ]
Frazier, Arthur [3 ]
Suisham, Stacey [3 ]
Parajuli, Prahlad [3 ]
Vaishampayan, Nitin [3 ]
Vaishampayan, Ulka [3 ]
机构：
[1] Wayne State Univ, Detroit, MI USA
[2] Roswell Pk, Buffalo, NY USA
[3] Karmanos Canc Ctr, Detroit, MI USA
来源：
JOURNAL FOR IMMUNOTHERAPY OF CANCER | 2019年 / 7卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
O24
引用
收藏
页数：2
相关论文
共 50 条
  • [31] A Phase I Trial of Dose-Escalated Image-Guided, Intensity Modulated Radiation Therapy in Combination with Concurrent Gemcitabine Chemotherapy for Node-Negative, Muscle-Invasive Bladder Cancer (MIBC)
    Kollmeier, M. A.
    Zelefsky, M. J.
    McBride, S.
    Debonis, D.
    Lochansingh, S.
    Varghese, M.
    Bochner, B.
    Rosenberg, J.
    Bajorin, D.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2018, 102 (03): : E87 - E88
  • [32] Phase II trial of nivolumab with chemotherapy as neoadjuvant treatment in inflammatory breast cancer.
    Kwa, Maryann J.
    Tray, Nancy
    Esteva, Francisco J.
    Novik, Yelena
    Speyer, James L.
    Oratz, Ruth
    Meyers, Marleen Iva
    Muggia, Franco
    Ty, Victor
    Troxel, Andrea
    Schneider, Robert
    Adams, Sylvia
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [33] Phase II study of concurrent chemoradiotherapy (CCRth) for bladder preservation in the treatment of muscle invasive bladder cancer
    El Taher, A. Mohamed
    Mekawy, M.
    Eid, S. Shehata
    Mostafa, H. G. El Din
    Aziz, A. M. Abdel
    Kamel, Y. Mostafa
    EJC SUPPLEMENTS, 2007, 5 (04): : 310 - 310
  • [34] Phase II Trial: Concurrent Chemotherapy and Radiation Therapy With Nitroglycerin in Locally Advanced Non-small Cell Lung Cancer Patients
    Blake, M.
    De la Mata, D.
    Zamora, J.
    Pena, O.
    Macedo, O.
    Flores Estrada, D.
    Turcott, J.
    Arrieta, O.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012, 84 (03): : S574 - S574
  • [35] Phase III trial of neoadjuvant chemotherapy in patients with invasive bladder cancer treated with selective bladder preservation by combined radiation therapy and chemotherapy: Initial results of Radiation Therapy Oncology Group 89-03
    Shipley, WU
    Winter, KA
    Kaufman, DS
    Lee, WR
    Heney, NM
    Tester, WR
    Donnelly, BJ
    Venner, PM
    Perez, CA
    Murray, KJ
    Doggett, RS
    True, LD
    JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (11) : 3576 - 3583
  • [36] Gemcitabine and cisplatin plus nivolumab as organ-sparing treatment for muscle-invasive bladder cancer: a phase 2 trial
    Galsky, Matthew D.
    Daneshmand, Siamak
    Izadmehr, Sudeh
    Gonzalez-Kozlova, Edgar
    Chan, Kevin G.
    Lewis, Sara
    Achkar, Bassam El
    Dorff, Tanya B.
    Cetnar, Jeremy Paul
    Neil, Brock O.
    D'Souza, Anishka
    Mamtani, Ronac
    Kyriakopoulos, Christos
    Jun, Tomi
    Gogerly-Moragoda, Mahalya
    Brody, Rachel
    Xie, Hui
    Nie, Kai
    Kelly, Geoffrey
    Horwitz, Amir
    Kinoshita, Yayoi
    Ellis, Ethan
    Nose, Yohei
    Ioannou, Giorgio
    Cabal, Rafael
    Haines, G. Kenneth
    Wang, Li
    Mouw, Kent W.
    Samstein, Robert M.
    Mehrazin, Reza
    Bhardwaj, Nina
    Yu, Menggang
    Zhao, Qianqian
    Kim-Schulze, Seunghee
    Sebra, Robert
    Zhu, Jun
    Gnjatic, Sacha
    Sfakianos, John
    Pal, Sumanta K.
    NATURE MEDICINE, 2023, 29 (11) : 2825 - +
  • [37] Gemcitabine and cisplatin plus nivolumab as organ-sparing treatment for muscle-invasive bladder cancer: a phase 2 trial
    Moschini, Marco
    Necchi, Andrea
    Montorsi, Francesco
    EUROPEAN UROLOGY, 2024, 85 (05) : 500 - 501
  • [38] Gemcitabine and cisplatin plus nivolumab as organ-sparing treatment for muscle-invasive bladder cancer: a phase 2 trial
    Matthew D. Galsky
    Siamak Daneshmand
    Sudeh Izadmehr
    Edgar Gonzalez-Kozlova
    Kevin G. Chan
    Sara Lewis
    Bassam El Achkar
    Tanya B. Dorff
    Jeremy Paul Cetnar
    Brock O. Neil
    Anishka D’Souza
    Ronac Mamtani
    Christos Kyriakopoulos
    Tomi Jun
    Mahalya Gogerly-Moragoda
    Rachel Brody
    Hui Xie
    Kai Nie
    Geoffrey Kelly
    Amir Horowitz
    Yayoi Kinoshita
    Ethan Ellis
    Yohei Nose
    Giorgio Ioannou
    Rafael Cabal
    Diane M. Del Valle
    G. Kenneth Haines
    Li Wang
    Kent W. Mouw
    Robert M. Samstein
    Reza Mehrazin
    Nina Bhardwaj
    Menggang Yu
    Qianqian Zhao
    Seunghee Kim-Schulze
    Robert Sebra
    Jun Zhu
    Sacha Gnjatic
    John Sfakianos
    Sumanta K. Pal
    Nature Medicine, 2023, 29 : 2825 - 2834
  • [39] Phase Ib neoadjuvant CG0070 and nivolumab (N) for cisplatin (C)-ineligible muscle invasive bladder cancer (MIBC)
    Li, Roger
    Spiess, Philippe E.
    Sexton, Wade J.
    Poch, Michael Adam
    Zemp, Logan
    Pow-Sang, Julio M.
    Zhang, Jingsong
    Dhillon, Jasreman
    Borjas, Gustavo
    Naidu, Shreyas U.
    Dorman, Denise
    Burke, James M.
    Mule, James J.
    Conejo-Garcia, Jose
    Jain, Rohit K.
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [40] Phase I/II trial of concurrent use of TS-1 in radiation therapy for laryngeal cancer
    Hayakawa, K.
    Nakayama, M.
    Kitano, M.
    Niibe, Y.
    Ishiyama, H.
    Kotani, S.
    Miyamoto, S.
    Takeda, M.
    Seino, Y.
    Okamoto, M.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2008, 72 (01): : S420 - S421
12345